Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China flag China · Delayed Price · Currency is CNY
17.21
+0.30 (1.77%)
Mar 10, 2026, 3:00 PM CST

Cisen Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
492.8508.91521.34349.96334.15438.78
Upgrade
Depreciation & Amortization
218.4218.4233.89230.25219.49159.98
Upgrade
Other Amortization
6.546.541.960.983.14-
Upgrade
Loss (Gain) From Sale of Assets
0.140.14-0.59-0.97-0.27-0.17
Upgrade
Asset Writedown & Restructuring Costs
56.6656.6674.2713.0621.3429.53
Upgrade
Loss (Gain) From Sale of Investments
-72.83-72.83-33.74-15.56-66.42-96.41
Upgrade
Provision & Write-off of Bad Debts
-4.16-4.162.3416.46-5.92-1.87
Upgrade
Other Operating Activities
271.1712.4410.846.83-1.688.38
Upgrade
Change in Accounts Receivable
-20.82-20.82-336.44-542.34-113.29-221.35
Upgrade
Change in Inventory
-115.04-115.04-144.3118.1-14.811.91
Upgrade
Change in Accounts Payable
4.554.55118.51197.67-113.8106.47
Upgrade
Change in Other Net Operating Assets
-25.94-25.94-4.92-18.73-9.261.64
Upgrade
Operating Cash Flow
813.48570.85451.24258.35233.6431.01
Upgrade
Operating Cash Flow Growth
88.16%26.51%74.67%10.59%-45.80%137.78%
Upgrade
Capital Expenditures
-112.28-101.81-17.71-35.19-51.02-202.27
Upgrade
Sale of Property, Plant & Equipment
2.370.490.760.010.491.22
Upgrade
Cash Acquisitions
--0.42---
Upgrade
Investment in Securities
1616-408.36-274.13289.99-84.04
Upgrade
Other Investing Activities
-403.0763.5746.7736.2388.02238.05
Upgrade
Investing Cash Flow
-496.98-21.75-378.13-273.08327.48-47.03
Upgrade
Short-Term Debt Issued
-----330
Upgrade
Long-Term Debt Issued
-53.335425013812.02
Upgrade
Total Debt Issued
28.6753.3354250138342.02
Upgrade
Short-Term Debt Repaid
------100.1
Upgrade
Long-Term Debt Repaid
--137.25-59.05-232.43-340.24-
Upgrade
Total Debt Repaid
-73.42-137.25-59.05-232.43-340.24-100.1
Upgrade
Net Debt Issued (Repaid)
-44.75-83.92-5.0517.57-202.24241.92
Upgrade
Issuance of Common Stock
-----42.73
Upgrade
Repurchase of Common Stock
------89.82
Upgrade
Common Dividends Paid
-203.37-304.56-156.13-139.54-120.73-279.99
Upgrade
Other Financing Activities
14.6423.8527.38230.164.541.2
Upgrade
Financing Cash Flow
-233.48-364.63-133.8108.19-318.43-83.96
Upgrade
Foreign Exchange Rate Adjustments
0.010.360.650.65-0.22-2.54
Upgrade
Net Cash Flow
83.03184.83-60.0494.11242.43297.48
Upgrade
Free Cash Flow
701.19469.04433.53223.15182.58228.74
Upgrade
Free Cash Flow Growth
91.32%8.19%94.27%22.22%-20.18%193.67%
Upgrade
Free Cash Flow Margin
19.68%11.78%9.71%5.49%4.83%6.23%
Upgrade
Free Cash Flow Per Share
1.541.030.960.490.400.51
Upgrade
Cash Interest Paid
0.450.450.60.440.380.44
Upgrade
Cash Income Tax Paid
309.85389.98433.03357.12390.99284.66
Upgrade
Levered Free Cash Flow
590.65499.47443.54283.19137.89350.92
Upgrade
Unlevered Free Cash Flow
591.74503.81447.66285.87141.7357.05
Upgrade
Change in Working Capital
-155.24-155.24-359.05-342.66-270.23-107.22
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.